Items where Gloucestershire Author is "Scanlon, Peter"

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Gruszka-Goh, Marta, Javed, Ushna, Vukic, Anthony, Hapeshi, Julie, Chave, Steve, Galsworthy, Paul, Vallance, Scott and Aldington, Stephen J. (2024) The scanning CONfoCal Ophthalmoscopy foR DIAbetic eye screening (CONCORDIA) study paper 2. Eye. doi:10.1038/s41433-024-03361-1 (In Press)

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Gruszka-Goh, Marta, Javed, Ushna, Vukic, Anthony, Hapeshi, Julie, Chave, Steve, Galsworthy, Paul, Vallance, Scott and Aldington, Stephen J. (2024) The Scanning CONfoCal Ophthalmoscopy foR DIAbetic eye screening (CONCORDIA) study paper 1. Eye. doi:10.1038/s41433-024-03360-2 (In Press)

Aravindhan, Amudha, Fenwick, Eva K., Chan, Aurora Wing Dan, Man, Ryan Eyn Kidd, Tan, Ngiap Chuan, Wong, Wei Teen, Soo, Wern Fern, Lim, Shin Wei, Wee, Sabrina Yi-Mei, Sabanayagam, Charumathi, Finkelstein, Eric, Tan, Gavin, Hamzah, Haslina, Chakraborty, Bibhas, Acharyya, Sanchalika, Shyong, Tai E., Scanlon, Peter H ORCID: 0000-0001-8513-710X, Wong, Tien Yin and Lamoureux, Ecosse L. (2024) Extending the diabetic retinopathy screening intervals in Singapore: methodology and preliminary findings of a cohort study. BMC Public Health, 24 (1). Art 786. doi:10.1186/s12889-024-18287-2 (In Press)

Jones, Rebecca, Stratton, Irene M, Scanlon, Peter H ORCID: 0000-0001-8513-710X and Theodoropoulou, Sofia (2023) Disengagement and loss to follow-up in intravitreal injection clinics for neovascular age-related macular degeneration. Eye, 37 (15). pp. 3186-3190. doi:10.1038/s41433-023-02474-3

Sivaprasad, Sobha, Ghanchi, Faruque, Kelly, Simon P., Kotagiri, Ajay, Talks, James, Scanlon, Peter H ORCID: 0000-0001-8513-710X, McGoey, Hellen, Nolan, Andrew, Saddiq, Moneeb and Napier, Jackie (2023) Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes. Eye, 37. pp. 2753-2760. doi:10.1038/s41433-023-02409-y

Sivaprasad, Sobha, Ghanchi, Faruque, Kelly, Simon P., Kotagiri, Ajay, Talks, James, Scanlon, Peter H ORCID: 0000-0001-8513-710X, McGoey, Hellen, Nolan, Andrew, Saddiq, Moneeb, Napier, Jackie and Morgan-Warren, Peter (2023) Evaluation of standard-of-care intravitreal aflibercept treatment practices in patients with diabetic macular oedema in the UK: DRAKO study outcomes. Eye, 37 (12). pp. 2527-2534. doi:10.1038/s41433-022-02367-x

Hernández, Cristina, Simó-Servat, Olga, Porta, Massimo, Grauslund, Jakob, Harding, Simon P., Frydkjaer-Olsen, Ulrik, García-Arumí, José, Ribeiro, Luísa, Scanlon, Peter H ORCID: 0000-0001-8513-710X, Cunha-Vaz, José and Simó, Rafael (2023) Serum glial fibrillary acidic protein and neurofilament light chain as biomarkers of retinal neurodysfunction in early diabetic retinopathy: results of the EUROCONDOR study. Acta Diabetologica, 60 (6). pp. 837-844. doi:10.1007/s00592-023-02076-1

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2022) Improving the screening of risk factors in diabetic retinopathy. Expert Review of Endocrinology and Metabolism, 17 (3). pp. 235-243. doi:10.1080/17446651.2022.2078305

Bressler, Susan B., Scanlon, Peter H ORCID: 0000-0001-8513-710X and Pearce, Elizabeth (2022) Why Is Continued Vision Loss Still a Problem in Some Patients With Diabetic Retinopathy, Despite Treatment? JAMA Ophthalmology, 140 (4). pp. 308-309. doi:10.1001/jamaophthalmol.2022.0135

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Norridge, Charlotte F. E., Donachie, Paul H. J. and Mohamed, Quresh (2022) Should we still be performing macular laser for non-centre involving diabetic macular oedema? Results from a UK centre. Eye, 36 (3). pp. 646-648. doi:10.1038/s41433-021-01789-3

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Nevill, Clareece R., Stratton, I M, Maruti, Sonia S., Sivaprasad, Sobha, Massó-González, Elvira L., Bailey, Clare, Ehrlich, Michael and Chong, Victor (2022) Prevalence and incidence of diabetic retinopathy (DR) in the UK population of Gloucestershire. Acta Ophthalmologica, 100 (2). e560-e570. doi:10.1111/aos.14927

Nevill, Clareece R., Stratton, Irene M., Maruti, Sonia S., Massó-González, Elvira L., Sivaprasad, Sobha, Bailey, Clare, Ehrlich, Michael, Chong, Victor and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2022) Epidemiology of moderately severe and severe non-proliferative diabetic retinopathy in South West England. Eye, 36 (2). pp. 433-440. doi:10.1038/s41433-021-01471-8

Talks, S. J., Stratton, I., Peto, T., Lotery, A., Chakravarthy, U., Eleftheriadis, H., Izadi, S., Dhingra, N., Scanlon, Peter H ORCID: 0000-0001-8513-710X, Talks, James, Mohamed, Quresh, Lotery, Andrew, Kashani, Sharam, Georgas, Nasos, Jones, Colin, Gashut, Abdisattar, Santiago, Cynthia, Chhabra, Romi, Antcliff, Richard, Dhingra, Naren, Bailey, Clare, Chakravarthy, Usha, Peto, Tunde, Ghanchi, Faruque, Mcinerney, Linda, Natha, Salim, Khan, Rehna, Dias, Indra, Mukhrejee, Raj, Izadi, Shahrnaz, Tahir, Irfan and Eleftheriadis, Haralabos (2022) Aflibercept in clinical practice; visual acuity, injection numbers and adherence to treatment, for diabetic macular oedema in 21 UK hospitals over 3 years. Eye, 36. pp. 72-77. doi:10.1038/s41433-021-01625-8

Sivaprasad, Sobha, Ghanchi, Faruque, Kelly, Simon P., Kotagiri, Ajay, Talks, James, Scanlon, Peter H ORCID: 0000-0001-8513-710X, McGoey, Hellen, Nolan, Andrew, Saddiq, Moneeb and Napier, Jackie (2022) Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes. Eye, 36. pp. 64-71. doi:10.1038/s41433-021-01624-9

Vujosevic, Stela, Cunha-Vaz, José, Figueira, João, Löwenstein, Anat, Midena, Edoardo, Parravano, Mariacristina, Scanlon, Peter H ORCID: 0000-0001-8513-710X, Simó, Rafael, Hernández, Cristina, Madeira, Maria H., Marques, Inês P., C.-V. Martinho, António, Santos, Ana R., Simó-Servat, Olga, Salongcay, Recivall P., Zur, Dinah and Peto, Tunde (2021) Standardization of Optical Coherence Tomography Angiography Imaging Biomarkers in Diabetic Retinal Disease. Ophthalmic Research, 64 (6). pp. 871-887. doi:10.1159/000518620

Tang, Fangyao, Wang, Xi, Ran, An-ran, Chan, Carmen K.M., Ho, Mary, Yip, Wilson, Young, Alvin L., Lok, Jerry, Szeto, Simon, Chan, Jason, Yip, Fanny, Wong, Raymond, Tang, Ziqi, Yang, Dawei, Ng, Danny S., Chen, Li Jia, Brelén, Marten, Chu, Victor, Li, Kenneth, Lai, Tracy H.T., Tan, Gavin S., Ting, Daniel S.W., Huang, Haifan, Chen, Haoyu, Ma, Jacey Hongjie, Tang, Shibo, Leng, Theodore, Kakavand, Schahrouz, Mannil, Suria S., Chang, Robert T., Liew, Gerald, Gopinath, Bamini, Lai, Timothy Y.Y., Pang, Chi Pui, Scanlon, Peter H ORCID: 0000-0001-8513-710X, Wong, Tien Yin, Tham, Clement C., Chen, Hao, Heng, Pheng-Ann and Cheung, Carol Y. (2021) A Multitask Deep-Learning System to Classify Diabetic Macular Edema for Different Optical Coherence Tomography Devices: A Multicenter Analysis. Diabetes Care, 44 (9). pp. 2078-2088. doi:10.2337/dc20-3064

Lois, Noemi, Cook, Jonathan, Wang, Ariel, Aldington, Stephen J, Mistry, Hema, Maredza, Mandy, McAuley, Danny, Aslam, Tariq, Bailey, Clare, Chong, Victor, Ghanchi, Faruque, Scanlon, Peter H ORCID: 0000-0001-8513-710X, Sivaprasad, Sobha, Steel, David, Styles, Caroline, Azuara-Blanco, Augusto, Prior, Lindsay and Waugh, Norman (2021) Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study. Health Technology Assessment, 25 (32). pp. 1-104. doi:10.3310/hta25320

Smith, John J, Wright, David M, Stratton, Irene M, Scanlon, Peter H ORCID: 0000-0001-8513-710X and Lois, Noemi (2021) Testing the performance of risk prediction models to determine progression to referable diabetic retinopathy in an Irish type 2 diabetes cohort. British Journal of Ophthalmology, 106 (8). pp. 1051-1056. doi:10.1136/bjophthalmol-2020-318570

Heydon, Peter, Egan, Catherine, Bolter, Louis, Chambers, Ryan, Anderson, John, Aldington, Steve, Stratton, Irene M, Scanlon, Peter H ORCID: 0000-0001-8513-710X, Webster, Laura, Mann, Samantha, du Chemin, Alan, Owen, Christopher G, Tufail, Adnan and Rudnicka, Alicja Regina (2021) Prospective evaluation of an artificial intelligence-enabled algorithm for automated diabetic retinopathy screening of 30 000 patients. British Journal of Ophthalmology, 105 (5). pp. 723-728. doi:10.1136/bjophthalmol-2020-316594

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2021) The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges. Acta Diabetologica, 58 (4). pp. 521-530. doi:10.1007/s00592-021-01687-w

Lois, Noemi, Cook, Jonathan A., Wang, Ariel, Aldington, Stephen J, Mistry, Hema, Maredza, Mandy, McAuley, Danny, Aslam, Tariq, Bailey, Clare, Chong, Victor, Ganchi, Faruque, Scanlon, Peter H ORCID: 0000-0001-8513-710X, Sivaprasad, Sobha, Steel, David H., Styles, Caroline, Azuara-Blanco, Augusto, Prior, Lindsay and Waugh, Norman (2021) Evaluation of a new model of care for people with complications of diabetic retinopathy: The EMERALD Study. Ophthalmology, 128 (4). pp. 561-573. doi:10.1016/j.ophtha.2020.10.030

Lanzetta, Paolo, Sarao, Valentina, Scanlon, Peter H ORCID: 0000-0001-8513-710X, Barratt, Jane, Porta, Massimo, Bandello, Francesco, Loewenstein, Anat, Eldem, Bora, Hunyor, Alex, Joussen, Antonia, Koh, Adrian, Korobelnik, Jean-François, Lanzetta, Paolo, Loewenstein, Anat, Lövestam-Adrian, Monica, Navarro, Rafael, Okada, Annabelle A., Pearce, Ian, Rodríguez, Francisco J., Staurenghi, Giovanni, Wolf, Sebastian and Wong, David T. (2020) Fundamental principles of an effective diabetic retinopathy screening program. Acta Diabetologica, 57. pp. 785-798. doi:10.1007/s00592-020-01506-8

Vujosevic, S., Aldington, S. J., Silva, P., Hernández, C., Scanlon, Peter H ORCID: 0000-0001-8513-710X, Peto, T. and Simó, R. (2020) Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes and Endocrinology, 8 (4). pp. 337-347. doi:10.1016/S2213-8587(19)30411-5

Chakravarthy, Usha, Bailey, Clare C., Scanlon, Peter H ORCID: 0000-0001-8513-710X, McKibbin, Martin, Khan, Rehna S., Mahmood, Sajjad, Downey, Louise, Dhingra, Narendra, Brand, Christopher, Brittain, Christopher J., Willis, Jeffrey R., Venerus, Alessandra, Muthutantri, Anushini and Cantrell, Ronald A. (2019) Direct Ophthalmic Healthcare Resource Use among Geographic Atrophy Patients in a Large Cohort from the United Kingdom. Ophthalmology Retina, 3 (11). pp. 920-926. doi:10.1016/j.oret.2019.06.012

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2019) Update on Screening for Sight-Threatening Diabetic Retinopathy. Ophthalmic Research, 62 (4). pp. 218-224. doi:10.1159/000499539

Avendaño-Veloso, Angélica, Parada-Hernández, Felipe, González-Ramos, Raúl, Dougnac-Osses, Camila, Carrasco-Sáez, José Luis and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2019) Teleophthalmology: a strategy for timely diagnosis of sight-threatening diabetic retinopathy in primary care, Concepción, Chile. International Journal of Ophthalmology, 12 (9). pp. 1474-1478. doi:10.18240/ijo.2019.09.16

Muqit, Mahi M. K., Aldington, Stephen J. and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2019) Quality Improvement of Laser Treatment (QUILT) A New Retinal Laser Simulation System for Training in Resource-Poor Countries. Retina, 39 (7). pp. 1430-1434. doi:10.1097/IAE.0000000000002586

Lois, Noemi, Cook, Jonathan, Aldington, Stephen J, Waugh, Norman, Mistry, Hema, Sones, William, McAuley, Danny, Aslam, Tariq, Bailey, Claire, Chong, Victor, Ghanchi, Faruque, Scanlon, Peter H ORCID: 0000-0001-8513-710X, Sivaprasad, Sobha, Steel, David, Styles, Caroline, McNally, Christine, Rice, Rachael, Prior, Lindsay and Azuara-Blanco, Augusto (2019) Effectiveness of Multimodal imaging for the Evaluation of Retinal oedema And new vesseLs in Diabetic retinopathy (EMERALD). BMJ Open, 9 (6). e027795. doi:10.1136/bmjopen-2018-027795

van Wijngaarden, Peter, Keel, Stuart and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2019) The Case for Extended Screening Intervals for People With Diabetes and No or Minimal Retinopathy at Baseline. JAMA Ophthalmology, 137 (4). pp. 449-459. doi:10.1001/jamaophthalmol.2018.6901

Leal, Jose, Luengo-Fernandez, Ramon, Stratton, Irene M., Dale, Angela, Ivanova, Katerina and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2019) Cost-effectiveness of digital surveillance clinics with optical coherence tomography versus hospital eye service follow-up for patients with screen-positive maculopathy. Eye, 33 (4). pp. 640-647. doi:10.1038/s41433-018-0297-7

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) Screening Intervals for Diabetic Retinopathy and Implications for Care. Current Diabetes Reports, 17. p. 96. doi:10.1007/s11892-017-0928-6

Moreton, R B, Stratton, I M, Chave, S J, Lipinski, H and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) Factors determining uptake of diabetic retinopathy screening in Oxfordshire. Diabetic Medicine, 34 (7). pp. 993-999. doi:10.1111/dme.13350

Santos, Ana Rita, Ribeiro, Luísa, Bandello, Francesco, Lattanzio, Rosangela, Egan, Catherine, Frydkjaer-Olsen, Ulrik, García-Arumí, José, Gibson, Jonathan, Grauslund DMSci, Jakob, Harding, Simon P, Lang, Gabriele E, Massin, Pascale, Midena, Edoardo, Scanlon, Peter H ORCID: 0000-0001-8513-710X, Aldington, Stephen J, Simão, Sílvia, Schwartz, Christian, Ponsati, Berta, Porta, Massimo, Costa, Miguel Ângelo, Hernández, Cristina, Cunha-Vaz, José and Simó, Rafael (2017) Functional and Structural Findings of Neurodegeneration in Early Stages of Diabetic Retinopathy. Cross-sectional Analyses of Baseline Data of the EUROCONDOR project. Diabetes, 66 (9). pp. 2503-2510. doi:10.2337/db16-1453

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) The English National Screening Programme for diabetic retinopathy 2003–2016. Acta Diabetologica, 54 (6). pp. 515-525. doi:10.1007/s00592-017-0974-1

Gale, R, Scanlon, Peter H ORCID: 0000-0001-8513-710X, Evans, M, Ghanchi, F, Yang, Y, Silvestri, G, Freeman, M, Maisey, A and Napier, J (2017) Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease. Eye, 31 (S1). S1-S20. doi:10.1038/eye.2017.53

Aldington, Stephen J and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) Conditions with appearances similar to diabetic retinopathy. In: Practical Manual of Diabetic Retinopathy Management. Wiley, Chichester, pp. 247-254. ISBN 9781119058953

Sallam, Ahmed and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) Proliferative diabetic retinopathy with maculopathy. In: Practical Manual of Diabetic Retinopathy Management, 2nd edition. Wiley Blackwell, Oxford, pp. 150-159. ISBN 9781119058953

Aldington, Stephen J and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) Conditions with appearances similar to diabetic retinopathy. In: Practical Manual of Diabetic Retinopathy Management, 2nd edition. Wiley Blackwell, Oxford, pp. 247-254. ISBN 9781119058953

Shaw, Jonathan and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) Diabetes. In: Practical Manual of Diabetic Retinopathy Management, 2nd edition. Wiley Blackwell, Oxford, pp. 15-25. ISBN 9781119058953

van Wijngaarden, Peter and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) Imaging techniques in diabetic retinopathy. In: Practical Manual of Diabetic Retinopathy Management, 2nd edition. Wiley Blackwell, Oxford, pp. 54-85. ISBN 9781119058953

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) Introduction. In: Practical Manual of Diabetic Retinopathy Management, 2nd edition. Wiley Blackwell, Oxford, pp. 1-14. ISBN 9781119058953

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) Lesions and classifications of diabetic retinopathy. In: Practical Manual of Diabetic Retinopathy Management, 2nd edition. Wiley Blackwell, Oxford, pp. 26-39. ISBN 9781119058953

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) Low vision and blindness from diabetic retinopathy. In: Practical Manual of Diabetic Retinopathy Management, 2nd edition. Wiley Blackwell, Oxford, pp. 207-218. ISBN 9781119058953

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) Mild non‐proliferative diabetic retinopathy. In: Practical Manual of Diabetic Retinopathy Management, 2nd edition. Wiley Blackwell, Oxford, pp. 116-119. ISBN 9781119058953

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) Moderate and severe non‐proliferative diabetic retinopathy. In: Practical Manual of Diabetic Retinopathy Management, 2nd edition. Wiley Blackwell, Oxford, pp. 120-127. ISBN 9781119058953

Aldington, Stephen J and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) Other retinal conditions in diabetes. In: Practical Manual of Diabetic Retinopathy Management, 2nd edition. Wiley Blackwell, Oxford, pp. 228-246. ISBN 9781119058953

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) Pregnancy and the diabetic eye. In: Practical Manual of Diabetic Retinopathy Management, 2nd edition. Wiley Blackwell, Oxford, pp. 197-206. ISBN 9781119058953

Sallam, Ahmed and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) Proliferative and advanced diabetic retinopathy. In: Practical Manual of Diabetic Retinopathy Management, 2nd edition. Wiley Blackwell, Oxford, pp. 128-149. ISBN 9781119058953

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) Screening for diabetic retinopathy. In: Practical Manual of Diabetic Retinopathy Management, 2nd edition. Wiley Blackwell, Oxford, pp. 40-53. ISBN 9781119058953

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) The stable treated eye. In: Practical Manual of Diabetic Retinopathy Management, 2nd edition. Wiley Blackwell, Oxford, pp. 160-170. ISBN 9781119058953

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Stratton, I. M., Bachmann, M. O., Jones, C. and Leese, G. P. (2016) Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age. Diabetic Medicine, 33 (12). pp. 1655-1658. doi:10.1111/dme.13263

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Stratton, I M, Leese, G P, Bachmann, M O, Land, M, Jones, C and Ferguson, B (2016) Screening attendance, age group and diabetic retinopathy level at first screen. Diabetic Medicine, 33 (7). pp. 904-911. doi:10.1111/dme.12957

Jamoom, E W, Heisey-Grove, D, Yang, N and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2016) Physician Opinions about EHR Use by EHR Experience and by Whether the Practice had optimized its EHR Use. Journal of Health and Medical Informatics, 7 (4). pp. 1-9. doi:10.4172/2157-7420.1000240

Oke, J L, Stratton, I M, Aldington, S J, Stevens, R J and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2016) The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme. Diabetic Medicine, 33 (7). pp. 896-903. doi:10.1111/dme.13053

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Aldington, Stephen J, Leal, Jose, Luengo-Fernandez, Ramon, Oke, Jason, Sivaprasad, Sobha, Gazis, Anastasios and Stratton, Irene M (2015) Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening. Health Technology Assessment, 19 (74). pp. 1-116. doi:10.3310/hta19740

Leese, Graham P., Stratton, Irene M, Land, Martin, Bachmann, Max O., Jones, Colin, Scanlon, Peter H ORCID: 0000-0001-8513-710X, Looker, Helen C. and Ferguson, Brian (2015) Progression of Diabetes Retinal Status Within Community Screening Programs and Potential Implications for Screening Intervals. Diabetes Care, 38 (3). pp. 488-494. doi:10.2337/dc14-1778

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Loftus, J, Starita, C. and Stratton, I M (2015) The use of weighted health-related Quality of Life scores in people with diabetic macular oedema at baseline in a randomized clinical trial. Diabetic Medicine, 32 (1). pp. 97-101. doi:10.1111/dme.12593

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2015) Diabetic Retinopathy. Medicine, 43 (1). pp. 13-19. doi:10.1016/j.mpmed.2014.10.009

Hipwell, A E, Sturt, J, Lindenmeyer, A, Stratton, I, Gadsby, R, O'Hare, P and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2014) Attitudes, access and anguish: a qualitative interview study of staff and patients' experiences of diabetic retinopathy screening. BMJ Open, 4 (12). pp. 1-9. doi:10.1136/bmjopen-2014-005498

Lindenmeyer, A, Sturt, J A, Hipwell, A, Stratton, I M, al-Athamneh, N, Gadsby, R, O'Hare, J P and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2014) Influence of primary care practices on patients' uptake of diabetic retinopathy screening: a qualitative case study. British Journal of General Practice, 64 (625). e484-e492. doi:10.3399/bjgp14X680965

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2014) Diabetic Eye Disease. In: Oxford Handbook of Endocrinology and Diabetes (Oxford Medical Handbooks). Oxford Univeristy Press, Oxford. ISBN 978-0199644438

Scanlon, Peter H ORCID: 0000-0001-8513-710X, van Wijngaarden, Peter and Dirani, Mohamed (2014) Screening for sight-threatening diabetic retinopathy: An update. Egyptian Retina Journal, 2 (1). pp. 3-18. doi:10.4103/2347-5617.152479

Keenan, T D, Johnston, R L, Donachie, P H, Sparrow, J M, Stratton, I M and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2013) United Kingdom National Ophthalmology Database Study: Diabetic Retinopathy; Report 1: prevalence of centre-involving diabetic macular oedema and other grades of maculopathy and retinopathy in hospital eye services. Eye, 27 (12). pp. 1397-1404.

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Aldington, S. J. and Stratton, I. M. (2013) Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy. Diabetic Medicine, 31 (4). pp. 439-442. doi:10.1111/dme.12313

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Stratton, Irene M., Histed, Mark, Chave, Steve J. and Aldington, Stephen J. (2013) The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010. Acta Ophthalmologica, 91 (5). e335-e339. doi:10.1111/aos.12074

Healy, Rachel, Sallam, Ahmed, Jones, Vanessa, Donachie, Paul H.J., Scanlon, Peter H ORCID: 0000-0001-8513-710X, Stratton, Irene M. and Johnston, Robert L. (2013) Agreement between photographic screening and hospital biomicroscopy grading of diabetic retinopathy and maculopathy. European Journal of Ophthalmology, 24 (4). pp. 550-558. doi:10.5301/ejo.5000404

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Aldington, Stephen J and Stratton, Irene M (2013) Epidemiological issues in diabetic retinopathy. Middle East African Journal of Ophthalmology, 20 (4). pp. 293-300. doi:10.4103/0974-9233.120007

Stratton, I M, Aldington, S J, Taylor, D J, Adler, A I and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2013) A Simple Risk Stratification for Time to Development of Sight-Threatening Diabetic Retinopathy. Diabetes Care, 36 (3). pp. 580-585. doi:10.2337/dc12-0625

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Provins, E., Craske, S., Chave, S., Aldington, S., Martin, C. and Stratton, I. (2013) Updating Diabetic Retinopathy Screening Lists using Automatic Extraction from GP Patient Records. Journal of Medical Screening, 20 (3). pp. 111-117. doi:10.1177/0969141313505747

Ross, A H, Donachie, P H J, Sallam, A, Stratton, I M, Mohamed, Q, Scanlon, Peter H ORCID: 0000-0001-8513-710X, Kirkpatrick, J N and Johnston, R L (2013) Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab? Eye, 27 (1). pp. 56-64. doi:10.1038/eye.2012.225

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2012) The Systematic DR Screening in England for Two Million People with Diabetes. In: Digital Teleretinal Screening: Teleophthalmology in Practice. Springer, London, pp. 127-136. ISBN 978-3642258091

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2012) Diabetic Retinopathy Screening – Progress or lack of Progress. In: Visual Dysfunction in Diabetes. The Science of Patient Impairment and Health Care. M.S. Humana Press (An Imprint of Springer), London, pp. 17-30. ISBN 978-1607611493

Sachdeva, Ashish, Stratton, Irene, Unwin, John, Moreton, Robert and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2012) Diabetic retinopathy screening: Study to determine risk factors for non-attendance. Diabetes and Primary Care, 14 (5). pp. 308-316.

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2012) The preferences of people with diabetes for diabetic retinopathy screening. Diabetic Medicine, 29 (7). pp. 836-837. doi:10.1111/j.1464-5491.2012.03630.x

Sallam, A, Scanlon, Peter H ORCID: 0000-0001-8513-710X, Stratton, I M, Jones, V, Martin, C N, Brelen, M and Johnston, R L (2011) Agreement and reasons for disagreement between photographic and hospital biomicroscopy grading of diabetic retinopathy. Diabetic Medicine, 28 (6). pp. 741-746. doi:10.1111/j.1464-5491.2011.03273.x

Hadley, G, Earnshaw, J J, Stratton, I, Sykes, J and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2011) A Potential Pathway for Managing Diabetic Patients with Arterial Emboli Detected by Retinal Screening. European Journal of Vascular and Endovascular Surgery, 42 (2). pp. 153-157. doi:10.1016/j.ejvs.2011.04.031

Chu, C. and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2011) Vitamin B12 deficiency optic neuropathy detected by asymptomatic screening. Case Reports, 2011 (apr21). bcr0220113823-bcr0220113823. doi:10.1136/bcr.02.2011.3823

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2010) Deterioration in vision after commencing insulin treatment (the early worsening phenomenon). In: HbA1c in Diabetes - Case studies in IFCC Units. Wiley-Blackwell, Oxford, p. 66. ISBN 978-1444334449

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2010) Why do patients still require surgery for the late complications of Proliferative Diabetic Retinopathy? Eye, 24 (3). pp. 435-440. doi:10.1038/eye.2009.320

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2010) Diabetic Retinopathy. In: Textbook of Diabetes: A Clinical Approach. John Wiley and Sons Ltd, Chichester, West Sussex, UK, pp. 575-598. ISBN 978-1405191814

West, S D, Groves, D C, Lipinski, H J, Nicoll, D J, Mason, R H, Scanlon, Peter H ORCID: 0000-0001-8513-710X and Stradling, J R (2010) The prevalence of retinopathy in men with Type 2 diabetes and obstructive sleep apnoea. Diabetic Medicine, 27 (4). pp. 423-430. doi:10.1111/j.1464-5491.2010.02962.x

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Aldington, Stephen, Wilkinson, Charles and Matthews, David (2009) Practical Manual of Diabetic Retinopathy Management’. Practical Manual . Wiley-Blackwell. ISBN 978-1405170352

Taylor, David J, Goatman,, Keith A, Gregory, Adam, Histed, Mark, Martin, Christian N, Warburton, Trevor J and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2009) Image-quality standardization for diabetic retinopathy screening. Expert Review of Ophthalmology, 4 (5). pp. 469-476. doi:10.1586/eop.09.39

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Carter, S C, Foy, C, Husband, R F A, Abbas, J and Bachmann, M O (2008) Diabetic retinopathy and socioeconomic deprivation in Gloucestershire. Journal of Medical Screening, 15 (3). pp. 118-121. doi:10.1258/jms.2008.008013

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2008) The English national screening programme for sight-threatening diabetic retinopathy. Journal of Medical Screening, 15 (1). pp. 1-4. doi:10.1258/jms.2008.008015

Atan, D, Foy, C and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2008) Reply to ‘Evaluation of the effect of JPEG and JPEG2000 image compression on the detection of diabetic retinopathy’. Eye, 22 (3). p. 471. doi:10.1038/sj.eye.6703019

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Foy, C and Chen, F K (2008) Visual acuity measurement and ocular co-morbidity in diabetic retinopathy screening. British Journal of Ophthalmology, 92 (6). pp. 775-778. doi:10.1136/bjo.2007.128561

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Martin, M. L., Bailey, C., Johnson, E., Hykin, P. and Keightley, S. (2006) Reported symptoms and quality-of-life impacts in patients having laser treatment for sight-threatening diabetic retinopathy. Diabetic Medicine, 23 (1). pp. 60-66. doi:10.1111/j.1464-5491.2005.01736.x

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Foy, C., Malhotra, R. and Aldington, S. J. (2005) The Influence of Age, Duration of Diabetes, Cataract, and Pupil Size on Image Quality in Digital Photographic Retinal Screening. Diabetes Care, 28 (10). pp. 2448-2453. doi:10.2337/diacare.28.10.2448

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Carter, S, Foy, C, Ratiram, D and Harney, B (2005) An evaluation of the change in activity and workload arising from diabetic ophthalmology referrals following the introduction of a community based digital retinal photographic screening programme. British Journal of Ophthalmology, 89 (8). pp. 971-975. doi:10.1136/bjo.2004.060723

Garvican, L and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2004) A pilot quality assurance scheme for diabetic retinopathy risk reduction programmes. Diabetic Medicine, 21 (10). pp. 1066-1074. doi:10.1111/j.1464-5491.2004.01300.x

Harding, S, Greenwood, R, Aldington, S, Gibson, J, Owens, D, Taylor, R, Kohner, E, Scanlon, Peter H ORCID: 0000-0001-8513-710X and Leese, G (2003) Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabetic Medicine, 20 (12). pp. 965-971. doi:10.1111/j.1464-5491.2003.01077.x

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Malhotra, R., Greenwood, R H, Aldington, S J, Foy, C, Flatman, M and Downes, S (2003) Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy. British Journal of Ophthalmology, 87 (10). pp. 1258-1263.

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Malhotra, R, Thomas, G, Foy, C, Kirkpatrick, J N, Lewis-Barned, N, Harney, B and Aldington, S J (2003) The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy. Diabetic Medicine, 20 (6). pp. 467-474.

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2001) Digital retinal photography in diabetic eye screening. Diabetes Technology and Therapeutics, 3 (2). pp. 187-191.

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2000) Screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy. Diabetes Technology and Therapeutics, 2 (2). pp. 283-287.